Education
About Us
Working with TipRanks
Follow Us
SelectQuote (SLQT)
NYSE:SLQT
SLQT Stock Chart & Stats
$0.89
$0.12(2.90%)
At close: 4:00 PM EST
$0.89
$0.12(2.90%)
Day’s Range― - ―
52-Week Range$0.81 - $6.21
Previous CloseN/A
Volume368.25K
Average Volume (3M)1.61M
Market Cap
$157.74M
Enterprise Value$593.38M
Total Cash (Recent Filing)$22.20M
Total Debt (Recent Filing)$457.83M
Price to Earnings (P/E)―
Beta1.24
Next Earnings
May 07, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding176,289,660
10 Day Avg. Volume2,466,592
30 Day Avg. Volume1,611,479
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.73
Price to Sales (P/S)0.27
P/FCF Ratio-30.25
Enterprise Value/Market Cap3.76
Enterprise Value/Revenue0.37
Enterprise Value/Gross Profit0.53
Enterprise Value/Ebitda3.64
Forecast
1Y Price Target
$4.00Price Target Upside349.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
De-risked Balance Sheet And Extended LiquidityThe new $415M facility materially extends debt maturities to 2031, raises revolver capacity and can lower interest costs. That structural improvement reduces refinancing risk, smooths seasonal liquidity needs tied to commissions receivable and gives management optionality for investments or buybacks over the medium term.
High And Durable Senior-segment MarginsThe senior business is the core cash engine: near‑record 39% margins and rising approved policy volume demonstrate strong unit economics and pricing power with carriers. Durable high margins in the flagship segment support sustainable earnings and cash generation even if growth moderates.
SelectRx (healthcare Services) Structural Growth And Clinical ImpactSelectRx shows durable, double‑digit member and revenue growth and produces measurable clinical outcomes (fewer hospital days). Those outcomes drive payer/carrier value, stickier relationships and growing recurring revenue, improving long‑term profitability and strategic diversification away from pure commission sales.
Bears Say
Weak And Inconsistent Cash ConversionOperating and free cash flows are positive but modest relative to revenue and volatile across years. Inconsistent cash conversion limits internal funding for marketing and margin expansion, increases reliance on credit facilities for seasonality, and raises sensitivity to one‑time reimbursement or carrier shocks.
Concentration Exposure To PBM/carrier Actions And Regulatory RatesMaterial, discrete actions by PBMs and national carriers produced a large guidance hit, highlighting structural concentration and contract risk. Ongoing CMS rate uncertainty and carrier marketing changes can persistently reduce enrollments, commissions, or reimbursement, compressing revenue and predictability.
Overall Profitability Remains Thin; Margin Durability UncertainAlthough earnings recovered from losses, consolidated margins are still narrow versus historical peaks. Thin margins increase vulnerability to commission rate moves, marketing cost inflation, or industry disruptions and constrain the company's ability to self‑fund growth or absorb further adverse carrier or regulatory changes.
SelectQuote News
SLQT FAQ
What was SelectQuote’s price range in the past 12 months?
SelectQuote lowest stock price was $0.81 and its highest was $6.21 in the past 12 months.
What is SelectQuote’s market cap?
SelectQuote’s market cap is $157.74M.
When is SelectQuote’s upcoming earnings report date?
SelectQuote’s upcoming earnings report date is May 07, 2026 which is in 80 days.
How were SelectQuote’s earnings last quarter?
SelectQuote released its earnings results on Feb 05, 2026. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.218 by $0.042.
Is SelectQuote overvalued?
According to Wall Street analysts SelectQuote’s price is currently Undervalued.
Does SelectQuote pay dividends?
SelectQuote does not currently pay dividends.
What is SelectQuote’s EPS estimate?
SelectQuote’s EPS estimate is >-0.01.
How many shares outstanding does SelectQuote have?
SelectQuote has 176,289,660 shares outstanding.
What happened to SelectQuote’s price movement after its last earnings report?
SelectQuote reported an EPS of $0.26 in its last earnings report, beating expectations of $0.218. Following the earnings report the stock price went down -28.966%.
Which hedge fund is a major shareholder of SelectQuote?
Currently, no hedge funds are holding shares in SLQT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SelectQuote Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (349.44% Upside)
$4.00 (349.44% Upside)
Blogger Sentiment
Bullish
SLQT Sentiment 66%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 437.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.87%
12-Months-Change
Fundamentals
Return on Equity
16.44%
Trailing 12-Months
Asset Growth
5.71%
Trailing 12-Months
Company Description
SelectQuote
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance policies to consumers from various insurance carriers in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related policies, including prescription drugs, dental, vision, and hearing plans; term life policies; and non-commercial auto and home property, and casualty policies. The company was incorporated in 1999 and is headquartered in Overland Park, Kansas.
SLQT Company Deck
SLQT Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call described strong operational execution: double‑digit consolidated revenue growth, near‑record senior margins (39%), rapid SelectRx revenue growth (26% YoY) and measurable clinical outcomes (20% fewer hospital days). Management secured a multiyear PBM agreement and a $415M credit facility that materially improves visibility and capital flexibility. However, the quarter and fiscal 2026 guidance were meaningfully impacted by two discrete headwinds (~$20M PBM reimbursement adjustment and ~$20M from a national carrier marketing cut), prompting a revised adjusted EBITDA range of $90–$100M and signaling near‑term uncertainty from industry disruption and preliminary CMS rate guidance. Overall the operational and cash flow improvements and strategic balance sheet actions outweigh the near‑term, largely one‑time headwinds, leaving management optimistic about long‑term profitability and cash generation.View all SLQT earnings summariesSLQT Stock 12 Month Forecast
Average Price Target
$4.00
▲(349.44% Upside)
Technical Analysis
Ownership Overview
29.70% Insiders
7.56% Mutual Funds
4.27% Other Institutional Investors
49.68% Public Companies and
Individual Investors